start
decemb
case
pneumonia
unknown
caus
began
appear
wuhan
hubei
provinc
china
subsequ
outbreak
pneumonia
quickli
spread
throughout
hubei
provinc
countri
world
pneumonia
confirm
result
novel
coronaviru
infect
accord
wholegenom
sequenc
januari
world
health
organ
tent
name
viru
novel
coronaviru
februari
china
offici
name
novel
coronaviru
pneumonia
ncp
later
februari
world
health
organ
offici
renam
ncp
coronaviru
diseas
mainli
character
pulmonari
inflamm
caus
damag
gastrointestin
tract
liver
nervou
system
also
caus
fever
cough
symptom
clinic
manifest
similar
viral
infect
thu
differenti
diagnosi
viral
infect
necessari
clinic
diagnosi
mainli
reli
laboratori
viru
nucleic
acid
detect
affect
viru
level
patient
sampl
collect
method
falseneg
result
frequent
observ
addit
numer
studi
report
chang
laboratori
detect
data
patient
studi
typic
focu
one
sever
hematolog
indic
limit
applic
research
result
therefor
comprehens
analyz
compar
laboratori
data
screen
patient
provid
basi
diagnosi
differenti
diagnosi
diseas
compar
influenza
nucleic
acid
test
detect
n
gene
qualiti
nucleic
acid
extract
monitor
use
intern
standard
posit
qualiti
control
weak
posit
qualiti
control
two
neg
qualiti
control
batch
use
two
gene
amplifi
cycl
threshold
ct
valu
detect
limit
result
consid
posit
singl
gene
detect
influenza
b
nucleic
acid
test
ct
valu
detect
limit
result
consid
posit
kit
provid
hunan
shengxiang
biolog
co
ltd
changsha
china
influenza
b
kit
provid
jiangsu
master
co
ltd
jiangsu
china
perform
verif
result
kit
follow
precis
test
show
kit
good
repeat
coeffici
variat
cv
ct
less
due
consider
biosafeti
verifi
accuraci
laboratori
particip
inter
laboratori
qualiti
assess
organ
shanghai
clinic
test
center
result
pass
sensit
kit
copiesml
interfer
test
show
volum
ratio
whole
blood
nasal
secret
concentr
runhou
tablet
solut
concentr
hydroxymethozolin
solut
effect
test
result
kit
cross
reaction
cytomegaloviru
influenza
viru
influenza
b
viru
chlamydia
pneumonia
mycoplasma
pneumonia
staphylococcu
aureu
perform
verif
result
influenza
b
viru
kit
follow
precis
test
show
detect
repeat
kit
good
coeffici
variat
cv
detect
ct
valu
less
equal
accuraci
result
show
neg
posit
complianc
rate
test
enterpris
referenceintern
standard
refer
sensit
kit
copiesml
interfer
test
show
volum
ratio
whole
blood
nasal
secret
concentr
runhou
tablet
solut
concentr
hydroxymethozolin
solut
effect
test
result
kit
cross
reaction
cytomegaloviru
chlamydia
pneumonia
mycoplasma
pneumonia
staphylococcu
aureu
etc
collect
blood
patient
use
routin
method
evalu
biochem
indic
blood
routin
indic
includ
lymphocyt
count
lym
lymphocyt
ratio
platelet
count
plt
white
blood
cell
count
wbc
plateletlarg
cell
ratio
monocyt
ratio
mono
monocyt
count
mono
red
blood
cell
count
red
blood
cell
volum
distribut
widthcv
red
blood
cell
volum
distribut
widthsd
hematocrit
mean
corpuscular
volum
mean
corpuscular
hemoglobin
mean
corpuscularhemoglobin
concentr
mean
platelet
volum
mpv
basophil
ratio
baso
basophil
count
baso
eosinophil
ratio
eo
eosinophil
count
eo
hemoglobin
plti
platelet
volum
distribut
width
pdw
thrombocytocrit
immatur
granulocyt
ratio
ig
absolut
valu
immatur
granulocyt
neutrophil
ratio
neutrophil
count
biochem
indic
includ
myoglobin
albumin
alb
ratio
albumin
globulin
carbon
dioxid
combin
power
co
serum
calcium
ca
serum
alanin
aminotransferas
alt
serum
aspart
amino
transferas
ast
astalt
serum
creatinin
serum
creatin
kinas
ck
serum
ck
isoenzym
mb
ckmb
serum
potassium
k
serum
chlorid
serum
magnesium
serum
sodium
serum
urea
serum
uric
acid
serum
globulin
serum
lactat
dehydrogenas
serum
inorgan
phosphoru
ip
anion
gap
serum
direct
bilirubin
serum
total
bilirubin
serum
total
bile
acid
serum
total
protein
tp
ddimer
c
reactiv
protein
procalcitonin
pct
median
interquartil
rang
calcul
continu
variabl
twotail
ttest
mannwhitney
test
use
appropri
compar
continu
variabl
data
differ
patient
group
normal
distribut
test
singl
sampl
kolmogorovsmirnov
test
p
valu
less
consid
indic
statist
signific
differ
spss
version
spss
inc
chicago
il
usa
use
data
analysi
statist
analysi
graph
gener
drawn
use
graphpad
prism
softwar
graphpad
inc
la
jolla
ca
usa
nucleic
acid
detect
swab
collect
patient
screen
detect
rate
nucleic
acid
detect
stool
specimen
posit
patient
examin
howev
nucleic
acid
detect
tear
sampl
posit
patient
period
detect
rate
patient
influenza
b
respect
tabl
fig
show
nucleic
acidposit
case
mainli
detect
januari
februari
februari
show
largest
number
posit
case
period
influenza
b
virus
also
present
case
detect
februari
patient
patient
show
decreas
lymphocyt
count
proport
patient
show
decreas
eosinophil
count
proport
patient
show
increas
creactiv
protein
fig
compar
laboratori
hematolog
indic
patient
neg
patient
patient
show
significantli
higher
level
hflc
mpv
mono
tp
alb
p
contrast
plti
wbc
lymph
baso
baso
eo
eo
plt
pct
absolut
valu
immatur
granulocyt
neot
urea
ip
significantli
decreas
p
compar
laboratori
hematolog
indic
patient
patient
influenza
ab
virus
patient
six
hematolog
indic
mpv
pdw
tp
alb
alt
co
cp
show
increas
level
p
contrast
eo
eo
ip
ckmb
clearli
reduc
p
highli
infecti
viru
transmit
droplet
contact
aerosol
fecalor
infect
make
difficult
prevent
control
china
addit
increas
risk
transmiss
caus
movement
peopl
plan
return
work
school
improv
laboratori
detect
capac
speed
diagnosi
need
facilit
earli
detect
isol
treatment
result
show
period
posit
rate
influenza
ab
infect
lead
influenza
outbreak
higher
infect
therefor
must
differenti
influenza
ab
ensur
appropri
patient
manag
patient
diagnos
influenza
ab
infect
coexist
condit
whether
virus
compet
requir
clinic
studi
result
show
detect
infect
concentr
januari
februari
peak
februari
posit
case
februari
case
part
china
import
wuhan
state
enact
time
prevent
control
measur
therefor
incub
period
viru
posit
rate
patient
infect
infect
influenza
ab
significantli
decreas
number
diagnos
case
countri
decreas
hundr
provinc
report
new
case
sever
day
also
detect
stool
sampl
eight
posit
patient
demonstr
stool
sampl
use
nucleic
acid
test
combin
pharyng
swab
stool
sampl
use
improv
posit
detect
rate
high
risk
infect
pharyng
swab
collect
howev
viral
nucleic
acid
detect
tear
posit
patient
suggest
first
infect
relat
eye
present
mention
chang
eosinophil
latest
diagnosi
treatment
plan
releas
chines
govern
increas
research
seen
report
eosinopenia
howev
compar
publish
literatur
studi
found
proport
eosinophil
chang
higher
among
patient
show
decreas
eosinophil
count
proport
may
relat
research
object
screen
patient
patient
earli
stage
diseas
bodi
emerg
respons
intens
declin
eosinophil
faster
relationship
eosinophil
diseas
sever
need
studi
also
comprehens
compar
laboratori
hematolog
indic
patient
patient
neg
infect
influenza
ab
compar
neg
patient
hflc
mpv
mono
tp
alb
increas
wherea
plti
wbc
lymph
baso
baso
eo
eo
plt
pct
ig
neot
urea
ip
decreas
compar
patient
infect
influenza
ab
mpv
pdw
tp
alb
alt
co
cp
increas
wherea
eo
eo
ip
ckmb
reduc
chang
mono
wbc
plt
plti
lymph
eo
eo
neot
serum
urea
alt
tp
alb
consist
result
previou
studi
hematolog
indic
hflc
mpv
pct
pdw
ig
co
cp
ip
ckmb
mention
therefor
hematolog
indic
provid
use
inform
author
declar
conflict
interest
